RealSelf Market Entry into South Korea: Segment Choice, Clinic Supply and Regulation

RealSelf is a US-based platform where people research cosmetic treatments through patient reviews, before-and-after photos and doctors' answers to their questions. As a product manager there, how would you help it expand into South Korea? ```hint Decide whom Korea means Before designing features, decide which patients and which clinics the Korean business serves first, and what RealSelf can offer them that the options they already use do not. ``` ### Clarifying Questions - Does expanding into South Korea mean serving Korean consumers who get treated at home, international patients who travel to Korean clinics, or both? - Is the goal near-term revenue from Korean clinics, user growth, or a strategic foothold in Asia, and over what time frame? - Are a partnership with or an acquisition of a local platform on the table, or should the plan assume RealSelf builds its own product? - Which treatments are in scope: surgical procedures only, or also non-surgical skin and injectable treatments? ### What a Strong Answer Covers - A clear read of the Korean market: demand for cosmetic care, the clinic landscape, entrenched local apps and channels, and the rules on medical advertising and health data - An explicit choice of first segment and entry wedge, justified by what RealSelf can do better than incumbents - Prioritized product changes for that segment, covering both patients and clinics - A business model and go-to-market for clinic supply that fit local rules without compromising review integrity - Success metrics with guardrails on review integrity and patient safety, and a phased plan with decision points ### Follow-up Questions - How would you keep clinics from seeding fake or paid reviews once Korean listings start driving bookings? - If Korean domestic users have not adopted the product after a year, would you invest more, partner or pull back, and what data would decide it? - How would aftercare work for a patient who flies home to another country a week after a procedure in Seoul?